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Abstract 
  
The ranking of the p-value of the true causal single nucleotide polymorphism in the ordered list of individual SNP 
p-values is an important factor for achieving success in the ultimate objective of association studies - identifying 
deleterious genetic variants. Thus, we undertake a study to assess the implications of complex, multimarker 
correlation structure, sample size and disease models on the ranking of the causal SNP. We carry out an extensive 
family-based candidate gene simulation study to analyze the position of the disease susceptibility locus in the 
complete list of individual SNP p-values ordered according to their statistical significance. We simulate data based 
on the haplotype distributions of ten randomly selected genes extracted from the HapMap database, various 
sample sizes (600,1000 and 2000) that current association studies employ, and disease models that mimic the 
characteristics of complex human disorders. 
We conclude that the average ranking of the causal SNP for sample sizes 600, 100 and 200 of 10.97, 9.65, and 8.34 
are dramatically distant from the most significant and intuitively appropriate top position. This result is even more 
pronounced for genes with high average correlation and large number of common SNPs. Moreover, the gain of the 
DSL ranking when comparing sample sizes 600 to 1000 and 1000 to 2000, averaged over disease models, causal 
SNPs and genes, was approximately 1.3. These outcomes both reveal the importance of the sample size and 
quantify the magnitude required to unequivocally determine the identity of the DSL in family-based candidate 
gene studies.  
Our results show the overwhelming importance of large sample sizes in the localization of deleterious SNPs even 
under simple disease models. These conclusions possess pronounced importance for the design and result 
interpretation of candidate gene, next generation high-density genome-wide association studies, as well as for the 
construction and implementation of association tests based on the distribution of the most significant (minimum 
p-value) test statistics. 
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Background 
There has been a continual effort in finding the best analytical methods for identifying disease causal mutations in 
the human genome. The chronological progression of the research methodology involves linkage analysis [Chioza, 
et al. 2009; King, et al. 2000], candidate gene studies [Mollaki, et al. 2009; Murphy, et al. 2009; Rakovski, et al. 
2007b] and currently, genome-wide association scans based on hundreds of thousands of single nucleotide 
polymorphisms (SNPs) with case-control [Barrett, et al. 2009; Beecham, et al. 2009; Check Hayden 2009; Himes, et 
al. 2009; Palmer, et al. 2009; van de Mortel, et al. 2000] and family-based data [Malarstig, et al. 2009; Van Steen 
and Lange 2005]. The ultimate objective of detecting and assessing the effects of the disease susceptibility loci 
(DSL) is predicated not only on the existence of significant corresponding test statistics p-values but also on their 
ranking in the sorted list of all (commonly SNP-specific) p-values. This is especially true with genome-wide 
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association scans due to the severity of the multiple testing problems which is generally handled by significance 
level adjustment methods that fail to reorder the test statistics. Thus, the emergence of the true DSL at the top of 
the significance list is pivotal for the success and replicability of genome-wide association scans.  
In current large-scale studies, the physical locations of the genotyped SNPs are usually far apart and linkage 
disequilibrium (LD) is not an issue. On the other hand, in family-based and case-control candidate gene association 
studies we come across high level of LD between the pairs of SNPs in candidate regions containing a putative 
deleterious allele which causes multiple significant p-values to arise from association testing. In fact, we generalize 
a related question about the induced test statistics correlation for pairs of SNPs in LD [Pritchard and Przeworski 
2001]. The problem of the position of the DSL in the significance ranking in candidate gene studies arises both from 
multiple testing and complex multimarker correlation structure represented by the region's haplotype distribution. 
Finally, the analysis of next generation genome-sequencing data [Check Hayden 2009; Pennisi 2009] will include a 
combination of both challenges, a dramatic increase of the magnitude of the multiple testing problem and an 
additional complexity of high correlations between closely positioned SNPs. In general, it is intuitive to expect that 
the most significant p-value will originate from the true causal SNP, but as with genome-wide association studies, 
this may not always be true. Lastly, there is a class of powerful testing strategies that are based on the distribution 
of the most significant (minimum p-value) individual marker test statistic that make the implicit assumption that 
the statistic with the minimum p-value corresponds to the causal SNP [Kimmel, et al. 2007; Rakovski, et al. 2007a]. 
We have undertaken a family-based simulation study to explore the validity of this assumption. 
  
Methods 
We simulated and analyzed family data consisting of family trios with complete data and discordant sib pairs with 
missing parental data. The results for both family designs were practically identical with respect to the question of 
interest; thus, in the subsequent presentation we report results for discordant sib-pairs data analyses only. With 
respect to data analyses approaches, we used the two natural tools for detecting difference in allele frequencies at 
a particular locus between related cases and controls, conditional logistic regression and the classical family-based 
test for association [van de Mortel, et al. 2000]. Since the results obtained under the implementation of both 
methods were extremely similar, we only report the outcomes of our work for conditional logistic regression. As 
customary, we employ additive coding of the marker genotypes by assigning values of 0, 1, and 2 to AA, Aa, and aa, 
respectively. In the conditional logistic regression model, we treated each family as a stratum containing the 
affected-unaffected pair of offspring and fitted all single covariate models to assess the unadjusted effect sizes of 
all markers in the candidate region. 
  
Simulation 
We randomly selected 10 genes from autosomal chromosomes of the human genome, extracted the resequenced 
unphased genotypes of the CEPH families from the publicly accessible ENCODE data from the HapMap database 
[Tanaka 2009] and calculated the corresponding haplotype distributions using the EM algorithm [Dempster, et al. 
1977] via its implementation in the FBAT software package [Girirajan, et al. 2009]. We used R version 2.9.2 
[Thauvin-Robinet, et al. 2009] for both the simulation of the genotype data and for the analysis of these data via 
FBAT and conditional logistic regression. Summary statistics of the ten genes are shown in Table 1.  
Table 1. Summary characteristics of the 10 genes. 
Gene Common SNPs* Mean MAF Mean r2 Size** Common 
Haplotypes*** 
1 18 0.14 0.38 21 4 
2 20 0.18 0.24 13 6 
3 30 0.30 0.42 11 5 
4 41 0.22 0.24 22 6 
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5 14 0.15 0.25 10 4 
6 61 0.24 0.39 19 6 
7 96 0.23 0.32 60 4 
8 29 0.30 0.37 34 4 
9 46 0.25 0.89 38 5 
10 36 0.18 0.37 17 5 
*Number of SNPs with minor allele frequency (MAF)> 0.05. 
**Measured in kilobase pairs (kb).  
***Number of haplotypes with frequency >0.05.  
  
We randomly paired haplotypes to create each of the parents and simulated pairs of offspring through Mendilian 
transmissions of haplotypes. Further, in consecutive simulation steps, we used six different disease models that 
mimic the small effect sizes of complex human disorders [Rakovski, et al. 2007b] to assign disease status to each 
offspring. We implemented two additive, two dominant and two recessive models defined through triplets of 
penetrance function with details shown in Table 2. For each of the ten genes and under each disease model, we 
simulated populations of families with pairs of offspring and created datasets of sizes 600, 1000 and 2000 by 
ascertainment of families with discordant offspring disease status. In each of the 1000 simulated dataset the causal 
SNP was randomly chosen and the parental genotypes were removed from the data and subsequent analyses. 
Summary statistics of the ten genes are shown in Table 2. 
Table 2. Disease models used in the simulation study. 
    Penetrance functions   
  f0 f1 f2 
Model 1 0.005 0.01 0.015 
Model 2 0.01 0.02 0.03 
Model 3 0.005 0.01 0.01 
Model 4 0.01 0.02 0.02 
Model 5 0.005 0.005 0.01 
Model 6 0.01 0.01 0.02 
  
Results 
Our results show the importance of the three analyzed factors: gene, disease model and sample size on the 
ranking of the DSL. Moreover, we present the outcome of our simulation study that describes the three-way 
interaction of these factors. The details on the ranking of the DSL p-value for each sample size, gene and disease 
model combinations are displayed in Tables 3, 4 and 5. 
Table 3. Ranking* of the DSL averaged over randomly chosen causal SNPs for sample size 600. 
  Gene 
Disease 
Model** 
1 2 3 4 5 6 7 8 9 10 
1 4.35 4.41 5.29 5.80 4.05 11.25 16.09 4.73 20.34 7.48 
2 3.97 4.06 5.71 7.38 3.50 13.73 18.03 4.94 20.10 8.23 
3 2.88 3.12 4.71 4.70 2.82 10.95 13.22 3.56 19.24 6.49 
4 3.07 3.48 4.72 4.95 2.72 11.02 13.71 3.44 17.87 6.51 
5 8.77 8.55 13.69 17.13 6.88 25.00 40.23 11.45 22.15 16.08 
6 9.20 8.70 13.88 17.96 7.02 26.79 38.89 12.23 23.11 14.14 
            *Ties among ranked p-values were resolved by assigning averages. 
** These six disease models are described in the Simulation Design section. 
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Table 4. Ranking* of the DSL averaged over the randomly chosen causal SNPs for sample size 1000. 
  Gene 
Disease 
Model** 
1 2 3 4 5 6 7 8 9 10 
1 2.53 3.64 4.39 5.05 3.26 7.86 14.59 3.12 18.37 6.92 
2 3.26 3.34 4.08 4.56 2.92 8.99 14.79 2.63 18.07 7.07 
3 1.93 2.83 4.04 3.66 2.09 8 8.72 3.23 17.39 5.35 
4 2.09 2.54 3.91 3.40 2.05 6.81 10.24 3.09 17.44 5.16 
5 9.04 8.65 10.34 15.26 7.04 22.97 40.44 8.98 22.26 16.19 
6 8.45 7.6 10.74 17.18 6.43 25.28 43.37 10.04 22.14 13.26 
            *Ties among ranked p-values were resolved by assigning averages. 
** These six disease models are described in the Simulation Design section. 
  
Table 5. Ranking* of the DSL averaged over the randomly chosen causal SNPs for sample size 2000. 
  Gene 
Disease 
Model** 
1 2 3 4 5 6 7 8 9 10 
1 2.18 3.21 3.66 3.63 1.77 7.53 9.02 2.47 18.54 5.78 
2 1.73 2.62 3.79 3.61 1.96 6.89 9.64 3.03 17.36 5.51 
3 1.64 2.49 3.70 3.48 1.67 5.90 7.45 2.60 17.15 4.79 
4 1.56 2.00 3.48 3.44 1.74 7.25 7.30 2.92 16.99 5.09 
5 7.96 7.26 9.54 16.41 6.06 20.73 29.68 8.98 21.50 12.73 
6 8.93 8.64 9.17 13.77 5.98 18.30 34.54 7.31 22.18 14.29 
            *Ties among ranked p-values were resolved by assigning averages. 
** These six disease models are described in the Simulation Design section.  
  
Table 3 shows the average ranking of the DSL p-value for sample size of 600. The three consistently least favorable 
results are associated with genes 6, 7 and 9 with rankings averaged over all disease models and causal SNPs (both 
unknown quantities) of 16.45, 23.36 and 20.47 respectively. These results are foreseeable as the above-mentioned 
genes possess the three largest numbers of common SNPs, 61, 96 and 46 and three of the top four biggest average 
correlations. In particular, the average correlation of the ten genes is 0.33 while the average correlation within 
gene 9 is 0.89. In contrast, the lowest rank of 2.72 was obtained for the combination of disease model 4 and gene 
5; this is the smallest candidate region with very low average correlation. On the other hand, disease models 3 and 
4 attained the highest rankings, averaged over all DSLs and genes, of 7.17 and 7.15. Models 1 and 2 performance 
followed closely with ranks of 8.38 and 8.96 while models 5 and 6 could only achieve average scores of 16.99 and 
17.19. However, these differences are expected due to the differences in the underlying distinctions in the effect 
sizes. Further, looking within disease models of the same type, the average increase taken over models 1, and 2, 3 
and 4, and 5 and 6 is only 0.3. Lastly, the ranking of the DSL for sample size 600 averaged over all simulation setting 
parameters is 10.97. 
Table 4 shows the average ranking of the DSL p-value for sample size of 1000. Again, genes 6, 7 and 9 attain the 
largest average rankings of 13.32, 22.02 and 19.28 respectively. The lowest rank of 1.93 was obtained for the 
combination of disease model 3 and gene 1; this is the second smallest candidate region which also possesses low 
average correlation. Moreover, as anticipated the order for all disease models is constant across sample sizes, 
models 3 and 4 attained rankings of 5.72 and 5.67, models 1 and 2 followed with 8.38 and 8.96 while models 5 and 
6 average achieve 16.99 and 17.19. Further, looking within disease models of the same type, the average increase 
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taken over models 1, and 2, 3 and 4, and 5 and 6 is only 0.1. Lastly, the ranking of the DSL for sample size 1000 
averaged over all simulation setting parameters is 9.65. 
Table 5 shows the average ranking of the DSL p-value for sample size of 2000. Similarly to the previous sample 
sizes, genes 6, 7 and 9 attain the largest average rankings of 11.10, 16.30 and 18.95 respectively. The lowest rank 
of 1.55 was obtained for the combination of disease model 4 and gene 1. Models 3 and 4 attained rankings of 5.10 
and 5.17, models 1 and 2 followed with 5.78 and 5.61 while models 5 and 6 average achieve 14.08 and 14.31. 
Further, looking within disease models of the same type, the average increase taken over models 1, and 2, 3 and 4, 
and 5 and 6 is only 0.05. Lastly, the ranking of the DSL for sample size 1000 averaged over all simulation setting 
parameters is 8.34. 
Interestingly, the ascendancy of the DSL across the ranking list as sample size increases is much slower than 
anticipated. We observe that the average ranking improves by only 1.3 as we increase the sample sizes from 600 
to 1000 and from 1000 to 2000. On the other hand, expectedly, based on their inherent characteristics, genes 6, 7, 
and 9 attain the lowest ranking regardless of sample size. Even sample size of 2000 is not sufficient to overcome 
the detrimental effect of large number of SNPs and high average correlation present within these genes. Further, 
for all simulated settings there are no observed DSL rankings of less than 2 for sample size 600 and there is only 
one such ranking (1.925) for sample size 1000. In contrast, for sample size 2000, we see multiple (7) average 
rankings of less than 2. Clearly, however, these conclusions are not particularly inspiring or helpful for the 
localization and identification of the causal SNP. 
  
Discussion 
We implemented a simulation-based study to explore the behavior of the ranking of the p-value of the DSL in 
family-based candidate gene association studies. We used classical FBAT as well as the Wald test arising from 
conditional univariate (SNP-specific) logistic regression models to carry out the statistical analyses. We did not use 
tagging SNPs because the deleterious variant might be absent from the set and that diverts the focus of the study 
in a different direction. 
There are several important conclusions with far-reaching consequences produced by our study. For all of the 
studied scenarios, the overall ranking of the DSL is dramatically distant from the intuitively anticipated top 
position. The departure is especially remarkable with smaller sample sizes and for genes with high average 
correlation and large number of common SNPs. This is a somewhat surprising result that contradicts the intuitive 
expectation that the DSL will likely yield the most significant p-value regardless of the correlation structure, gene 
span and sample size. The gain in the DSL ranking when comparing sample sizes 600 to 1000 and 1000 to 2000, 
averaged over disease models and genes, is approximately 1.3 .This reveals the magnitude of the sample sizes 
needed to precisely determine the location and identity of the DSL in family-based candidate gene studies. This 
problem could be further exacerbated if we are testing multiple genes matching a linkage peak, performing a 
second stage genome-wide scan or next generation genome sequence analysis.  
Lastly, minimum p-value-based association methods make the implicit assumption that the most significant test 
statistic is driven by and associated with the true causal SNP. We have shown that it is rarely the case and in the 
vast majority of the cases the most significant test corresponds to a SNP that is in LD with the causal SNP. This 
means that common practice to report the most significant results would potentially omit the DSL and make the 
findings unlikely to replicate in subsequent studies, especially in populations with different LD structure. 
  
Conclusions 
Our results underline the necessity of large sample sizes in the localization of deleterious SNPs even under simple 
disease models. These conclusions possess pronounced importance for the design and result interpretation of 
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candidate gene, next generation high-density genome-wide association studies, as well as for the construction and 
implementation of association tests based on the distribution of the most significant (minimum p-value) test 
statistics. 
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